Congenica

OverviewSuggest Edit

Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this research into a revolutionary clinical genomic analytics platform, Sapientia, for processing genome-wide data sets of human DNA sequence with deep clinical phenotype information in order to provide a definitive molecular diagnosis and clinically actionable interpretation for treatment, patient stratification and improved therapeutic discoveries.

TypePrivate
Founded2014
HQHinxton, GB
Websitecongenica.com

Latest Updates

Employees (est.) (Jul 2021)104(+6%)
Cybersecurity ratingAMore

Key People/Management at Congenica

David Atkins

David Atkins

CEO
Nick Lench

Nick Lench

Chief Scientific Officer
Andy Richards

Andy Richards

Chairman
Matthew Hurles

Matthew Hurles

Scientific Director
David Shi

David Shi

Non-Executive Director
Michael Anstey

Michael Anstey

Investment Director
Show more

Congenica Office Locations

Congenica has an office in Hinxton
Hinxton, GB (HQ)
Wellcome Trust Genome Campus
Show all (1)

Congenica Financials and Metrics

Summary Metrics

Founding Date

2014

Congenica total Funding

$82.2 m

Congenica latest funding size

$50 m

Time since last funding

9 months ago

Congenica investors

Congenica's latest funding round in November 2020 was reported to be $50 m. In total, Congenica has raised $82.2 m
Show all financial metrics

Congenica Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Congenica Online and Social Media Presence

Embed Graph

Congenica News and Updates

Congenica Receives CE Mark for Genomic Analysis Software

Congenica Receives CE Mark for Genomic Analysis Software

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica Launches Patient Advocacy and Engagement Advisory Board

Congenica Launches Patient Advocacy and Engagement Advisory Board

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Show more

Congenica Blogs

Unleash Molecular Superpowers with Next-Generation Genomic Analysis

Unleash Your Molecular Superpowers with Next-Generation Genomic Analysis Software

How we learnt about Menkes Syndrome

For our latest patient guest blog, we welcome Daniel DeFabio, Co-Founder of DISORDER: The Rare Disease Film Festival. Daniel and his wife Tina lost their eldest son Lucas when he was 11 years old to Menkes Syndrome, a very rare genetic disorder. Here Daniel shares his story.  

Senior Regulatory Affairs Manager (Global)

The post Senior Regulatory Affairs Manager (Global) appeared first on Congenica.

Discovering Glut1 Deficiency Syndrome

July 10 2021 is the first ever International Glut1 Awareness Day. In recognition of this inaugural event, and to help raise awareness of this rare disease, we welcome guest blogger Trudy Morgan, European Outreach Director Glut1 Deficiency Foundation and Chair, Glut1 Deficiency UK to tal…

David Atkins welcomes the Government's Life Sciences Sector Vision

A press release from the BIA UK BioIndustry Association (BIA) released on 6 July welcomes the Government's new Life Sciences Sector Vision, quoting Congenica CEO David Atkins on the benefits that this will deliver to the genomics sector in the UK.

Diagnosing CALFAN syndrome after years of uncertainty

Life-Changing Answers - Congenica Genomics Clinical Case Series
Show more

Congenica Frequently Asked Questions

  • When was Congenica founded?

    Congenica was founded in 2014.

  • Who are Congenica key executives?

    Congenica's key executives are David Atkins, Nick Lench and Andy Richards.

  • How many employees does Congenica have?

    Congenica has 104 employees.

  • Who are Congenica competitors?

    Competitors of Congenica include Phosphorus, Mission Bio and Senti Biosciences.

  • Where is Congenica headquarters?

    Congenica headquarters is located at Wellcome Trust Genome Campus, Hinxton.

  • Where are Congenica offices?

    Congenica has an office in Hinxton.

  • How many offices does Congenica have?

    Congenica has 1 office.